EROSIVE PUSTULAR DERMATOSIS

This adverse event was reported 50 times

These drugs are most commonly taken by patients reporting EROSIVE PUSTULAR DERMATOSIS:

# Drug Count
0 PEMETREXED DISODIUM 21
1 PEMETREXED 20
2 CARBOPLATIN 19
3 AMIVANTAMAB-VMJW 17
4 DOXYCYCLINE 8
5 DOXYCYCLINE HYCLATE 8
6 ERLOTINIB HYDROCHLORIDE 7
7 CHLORPHENIRAMINE MALEATE 6
8 ACETAMINOPHEN 5
9 ACETAMINOPHEN 500MG 5
See all common drugs associated with EROSIVE PUSTULAR DERMATOSIS

EROSIVE PUSTULAR DERMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMIVANTAMAB-VMJW 17 0.0048
1 LAZERTINIB 2 0.0023
2 ACEBUTOLOL HYDROCHLORIDE 1 0.0008
3 CALCIPOTRIENE 2 0.0006
4 ERLOTINIB HYDROCHLORIDE 7 0.0006
5 PEMETREXED DISODIUM 21 0.0005
6 CEMIPLIMAB-RWLC 1 0.0005
7 ACITRETIN 1 0.0002
8 DASPONE 2 0.0002
9 DAPSONE GEL, 5% 2 0.0002
See all drugs enriched for association with EROSIVE PUSTULAR DERMATOSIS

EROSIVE PUSTULAR DERMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sulfone [EPC] 2 0.0002
1 Tetracycline-class Drug [EPC] 8 0.0001
2 Vitamin D Analog [EPC] 2 0.0001
3 Alkaloid [EPC] 2 0.0001
4 Platinum-based Drug [EPC] 19 0.0001
5 Folate Analog Metabolic Inhibitor [EPC] 23 0.0001
6 Vitamin D [EPC] 4 0.0000
7 Vitamin B12 [EPC] 4 0.0000
8 Retinoid [EPC] 3 0.0000
9 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
See all drug classes enriched for association with EROSIVE PUSTULAR DERMATOSIS